Long-Acting IL-7 and Oncolytic Virus Combo Improves Glioblastoma Immunotherapy in Mouse Study
A new "expand and pull" treatment strategy combines long-acting interleukin-7 and oncolytic virus therapy to boost T cell response in glioblastoma. In mouse models, the combination improved cytotoxic T cell function and led to long-term tumor-free survival.